WHO Suspends Hydroxychloroquine Trial Over Safety Concerns

SMS
WHO Suspends Hydroxychloroquine Trial Over Safety Concerns
The WHO is pausing testing on hydroxychloroquine for a week or two while it reviews data to make sure it's safe to continue testing it.
SHOW TRANSCRIPT

The World Health Organization said it's going to temporarily suspend testing on hydroxychloroquine as a potential coronavirus treatment because of safety concerns. The WHO made the announcement during a news briefing on Monday. 

"The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board," WHO Director-General Tedros Adhanom Ghebreyesus said. "The other arms of the trial are continuing."

The decision comes shortly after a large study found increased risk of heart problems and death in COVID-19 patients who received chloroquine and hydroxychloroquine.

President Donald Trump has repeatedly touted the anti-malarial drug as a potential treatment for COVID-19. He's even revealed that he was taking it to prevent COVID-19. 

WHO officials said it would stop testing hydroxychloroquine for a week or two while the board reviews the data to decide if it's safe to keep going. Chloroquine is not part of the trial.